Cipher Pharmaceuticals Stock Overlap Studies Midpoint Price over period
| CPH Stock | CAD 14.86 0.30 2.06% |
| Symbol |
The output start index for this execution was two with a total number of output elements of fifty-nine. The Mid-point Price over period is an average of Cipher Pharmaceuticals highest and lowest prices attained during the given period.
Cipher Pharmaceuticals Technical Analysis Modules
Most technical analysis of Cipher Pharmaceuticals help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cipher from various momentum indicators to cycle indicators. When you analyze Cipher charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Cipher Pharmaceuticals Predictive Technical Analysis
Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cipher Pharmaceuticals. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cipher Pharmaceuticals based on widely used predictive technical indicators. In general, we focus on analyzing Cipher Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cipher Pharmaceuticals's daily price indicators and compare them against related drivers, such as overlap studies and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Cipher Pharmaceuticals's intrinsic value. In addition to deriving basic predictive indicators for Cipher Pharmaceuticals, we also check how macroeconomic factors affect Cipher Pharmaceuticals price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
| 2023 | 2024 (projected) | Dividend Yield | 0.0514 | 0.0458 | Price To Sales Ratio | 5.03 | 4.78 |
Be your own money manager
As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.Generate Optimal Portfolios
Align your risk and return expectations
Other Information on Investing in Cipher Stock
Cipher Pharmaceuticals financial ratios help investors to determine whether Cipher Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cipher with respect to the benefits of owning Cipher Pharmaceuticals security.